Redmile Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-265,736
Closed -$33.3M 101
2020
Q4
$33.3M Sell
265,736
-12,200
-4% -$1.36M 0.4% 54
2020
Q3
$28.2M Sell
277,936
-1,400
-0.5% -$143K 0.52% 50
2020
Q2
$27.2M Sell
279,336
-163,364
-37% -$15.2M 0.5% 51
2020
Q1
$36.8M Sell
442,700
-7,100
-2% -$692K 1.03% 31
2019
Q4
$50M Buy
449,800
+54,400
+14% +$5.6M 1.2% 26
2019
Q3
$39.2M Buy
+395,400
New +$39.3M 1.31% 24
2019
Q2
Sell
-174,000
Closed -$19.2M 97
2019
Q1
$19.2M Sell
174,000
-20,800
-11% -$2.17M 0.56% 47
2018
Q4
$17.9M Sell
194,800
-5,200
-3% -$526K 0.72% 43
2018
Q3
$22M Buy
+200,000
New +$20.8M 0.68% 51
2018
Q2
Sell
-245,314
Closed -$20.4M 89
2018
Q1
$20.4M Sell
245,314
-5,300
-2% -$471K 0.79% 38
2017
Q4
$22.8M Sell
250,614
-151,400
-38% -$12.6M 0.99% 37
2017
Q3
$30.6M Buy
+402,014
New +$30.4M 1.51% 24

Other funds holding PRAH